During the past decade, UCLA Clinical & Translational Research Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Clinical & Translational Research Center" #1 collaborator was "ModernaTX, Inc." with 1 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Clinical & Translational Research Center" are "Astrocytoma" (1 trials), "Depression" (1 trials), "Duchenne Muscular Dystrophy" (1 trials), "Immunosuppression" (1 trials) and "Lung Transplant Recipient" (1 trials). Many other conditions were trialed in "UCLA Clinical & Translational Research Center" in a lesser frequency.

Most popular intervention types in "UCLA Clinical & Translational Research Center" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "PF-06252616" (1 trials), "PF-06840003" (1 trials), "Rituximab-EU+ Rituximab-Pfizer x 2 Courses" (1 trials), "Rituximab-Pfizer (PF-05280586) x 3 courses" (1 trials) and "Rituximab-US + Rituximab-Pfizer x 2 Courses" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Clinical & Translational Research Center" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "UCLA Clinical & Translational Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UCLA Clinical & Translational Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Clinical & Translational Research Center, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".